Bourne, Christina R

Veterinary Pathobiology
250 McElroy Hall
Stillwater, OK 74078
Office: (405) 744-6736
Send eMail

2012 - present  Associate Research Scientist

2007 - present  Assistant Research Scientist

                         Oklahoma State University, Department of Veterinary Pathobiology

                         Laboratory of Dr. William Barrow

2005 - 2007  American Cancer Society Mary Horton Postdoctoral Fellow

                        University of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology

                        Research Focus: Anti-viral development of a Hepatitis B virus capsid protein assembly inhibitor

                        Mentor:  Dr. Adam Zlotnick

2003 - 2005  Postdoctoral Fellow

                        University of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology

                        Research Focus: Structural studies of the Hepatitis B virus capsid protein

                        Mentor:  Dr. Adam Zlotnick

1998 - 2003  Doctor of Philosophy

                       Oklahoma Medical Research Foundation, Department of Crystallography

                       University of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology

                       Dissertation:  Biochemical characterization and three-dimensional structures of the Fab and Fc

                       portions of a human IgG1 antibody

                       Mentor: Allen B. Edmundson, Ph.D.

Abstract concepts make more sense with a vivid picture.  I pursue the visualization of molecules by application of crystallographic techniques.  The end results allows us to view the molecule in question, infer functional aspects, and if present in the experiment to understand how a small molecule binds and could affect the function.  I am currently using the same process in the development of new antibiotics, in addition to techniques including biochemistry and chemical biology.

2011-present    Member, BEI Resources Scientific Focus Group for Biodefense and High Containment bacteria

2011-present    Member, Advisory Board, Journal of Molecular Recognition

2010                  Guest scientist for Stillwater area “Born to do Science” science outreach program

2009                  MolSoft2009 Workshop on Modern Drug Target Crystallography and Structure Based Drug Discovery,

                                    San Diego, CA

2006-present    Ad Hoc reviewer: Journal of Antimicrobial Chemotherapy, Acta Crystallographica D,

                                  Acta Crystallographica F, Journal of Molecular Recognition

2000                  Participant in RapiData Biology Department, National Synchrotron Light Source,

                                 Brookhaven National Laboratory, Upton, NY

1999                  Oklahoma State University Mini-Course in Protein Purification, Stillwater, OK

1998                  Light Scattering University, Wyatt Technology, Santa Barbara, CA

2012-present  Member, International Chemical Biology Society

2008-present  Member, American Society for Microbiology

2006-2007       Member, American Society of Virology

2003-present  Member, American Society for Biochemistry and Molecular Biology

2001-present  Member, American Crystallographic Association

2001                President, Alpha Epsilon Lambda Honor Society (OUHSC branch)

1998-2006       Member, American Chemical Society

Bourne, C.R., Wakeham, N., Nammalwar, B., Tseitin, V., Bourne, P.C., Barrow, E.W., Ramnarayan, K., Bunce, R.A., Berlin, K.D., Barrow, W.W. (2012) Structure-activity relationships guide enantiomeric preference among potent inhibitors of B. anthracis dihydrofolate reductase. Biochemica et Biophysica Acta: Proteins and Proteomics, under revision.

Nammalwar, B., Bourne, C.R., Bunce, R.A., Wakeham, N., Bourne, P.C., Ramnarayan, K., Mylvaganam, S., Berlin, K.D., Barrow, E.W., Barrow, W.W.  (2012)  6-Alkyl-2,4-diaminopyrimidine Inhibitors of Bacterial Dihydrofolate Reductase Can Open a Side Pocket Containing Conserved Waters.  ChemMedChem, under revision.

Nammalwar, B., Bunce, R. A., Berlin, K. D., Bourne, C. R., Bourne, P. C., Barrow, E. W., Barrow, W. W.  (2012) Heck synthesis of 2,4-diaminopyrimidine-based antibiotics using the Frech catalyst. Tetrahedron Letters In Press.

Barrow, E., Clinkenbeard, P., Duncan-Decocq, R., Perteet, R., Hill, K., Bourne, P.,  Valderas, M., Bourne, C., Clarkson, N., Clinkenbeard, K., Barrow, W.  (2012) High-throughput screening of a diversity collection using biodefense category A and B Priority pathogens.  Journal of Biomolecular Screening In Press, ePub May 31, 2012

Nammalwar, B., Bunce, R.A., Berlin, K.D., Bourne, C.R., Bourne, P.C., Barrow, E.W., Barrow, W.W.  (2012) Synthesis and biological activity of substituted 2,4-diaminopyrimidines that inhibit Bacillus anthracis.  European Journal of Medicinal Chemistry In Press, ePub May 21, 2012

Nammalwar, B., Bunce, R. A., Berlin, K. D., Bourne, C. R., Bourne, P. C., Barrow, E. W., Barrow, W. W. (2012) Microwave-assisted Heck synthesis of substituted 2,4-diaminopyrimidine-based antibiotics. Organic Preparations and Procedures International. 44:281-87.

Bourne, C.R., Wakeham, N., Bunce, R.A., Nammalwar, B., Berlin, K.D., Barrow, W.W.  (2012) Classifying compound mechanism of action for linking whole cell phenotypes to molecular targets.  Journal of Molecular Recognition 25:216-23.

Bourne, C.R., Barrow, E.W., Bunce, R.A., Bourne, P.C., Berlin, K.D., Barrow, W.W.  (2010) Inhibition of antibiotic resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.  Antimicrobial Agents and Chemotherapy 54(9): 3825-33.

Bunce, R.A., Bourne, C.R., Bourne, P.C., Barrow, E.B., Barrow, W.W., Berlin, K.D.  (2010) HPLC Detection and enantiomeric Separation of (+)- and (-)-(E)-3-[5-(2,4-diaminopyrimidin-5-ylmethyl)-2,3-dimethoxyphenyl]-1-(1-propyl-1h-phthalazin-2-yl)propenone, inhibitors of Bacillus anthracis dihydrofolate reductase, by supercritical fluid chromatography.  Proc. Of the Oklahoma Academy of Science 90:139-142.

C.R. Bourne, R.A. Bunce, P.C. Bourne, K.D. Berlin, E.W. Barrow, W.W. Barrow  (2009) Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.  Antimicrobial Agents and Chemotherapy 53 (7): 3065-73.

C.R. Bourne, S.P. Katen, M.R. Fulz, C. Packianathan, A. Zlotnick (2009) A mutant Hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly.  Biochemistry 48 (8): 1736-42.

C. Bourne, S. Lee, B. Venkataiah, A. Lee, B. Korba, M.G. Finn, A. Zlotnick (2008) Small-molecule effectors of Hepatitis B virus capsid assembly give insight into virus lifecycle.  Journal of Virology 82: 10262-70.

A. Zlotnick, A. Lee, C.R. Bourne, J.M. Johnson, P.L. Domanico, S.J. Stray (2007) In vitro screening for molecules that affect virus capsid assembly and other protein association reactions.  Nature Protocols 2 (3): 490-98.  *Journal cover was figure for this manuscript

C.R. Bourne, M.G. Finn, A. Zlotnick (2006) Global structural changes in Hepatitis B capsids induced by the assembly effector HAP1.  Journal of Virology 80 (22): 11055-61.

P.A. Ramsland, S.S. Terzyan, G. Cloud, C.R. Bourne, W. Farrugia, G. Tribbick, M.H. Geysen, C.R. Moomaw, C.A. Slaughter, A.B. Edmundson (2006) Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody.  Biochemical Journal 395 (3): 473-81.

S.J. Stray, C.R. Bourne, S. Punna, W.G. Lewis, M.G. Finn, A. Zlotnick (2005) A heteroaryldihydropyrimidine activates and can misdirect Hepatitis B virus capsid assembly.  Proceedings of the National Academies of Science USA 102 (23):8138-40.

S.S. Terzyan, C.R. Bourne, P.A. Ramsland, P.C. Bourne, A.B. Edmundson (2003) Comparison of the three-dimensional structures of a human Bence-Jones dimer crystallized on earth and aboard U.S. Space Shuttle Mission STS-95.  Journal of Molecular Recognition 16 (2): 83-90.

P.C. Bourne, P.A. Ramsland, L. Shan, Z.-C. Fan, C.R. DeWitt, B.B. Shultz, S.S. Terzyan, C.R. Moomaw, C.A. Slaughter, L.W. Guddat, A.B. Edmundson (2002) Three-dimensional structure of an immunoglobulin light-chain dimer with amyloidogenic properties.  Acta Crystallographica D58: 815-23.

P.A. Ramsland, J.L. Upshaw, B.B. Shultz, C.R. DeWitt, W.F. Chissoe, R.L. Raison, A.B. Edmundson (2001) Interconversion of different crystal forms of Fabs from human IgM cryoglobulins.  Journal of Crystal Growth 232: 204-14.

R.H. Broyles, V. Belegu, C.R. DeWitt, S.N. Shah, C.A. Steward, Q.N. Pye, R.A. Floyd (2001) Specific repression of beta-globin promoter activity by nuclear ferritin. Proceedings of the National Academies of Science USA 98 (16): 9145-50.

U.R.  Alvarado, C.R. DeWitt, B.B. Shultz, P.A. Ramsland, A.B. Edmundson (2001) A method for growing protein crystals in capillary tubes.  Journal of Crystal Growth 233: 407-14.

A.B. Edmundson, C.R. DeWitt, B.Z. Goldsteen, P.A. Ramsland (1999) Packing motifs as predictors of the propensity of antibody fragments to crystallize.  Journal of Crystal Growth 196: 276-84.

A.B. Edmundson, B.Z. Goldsteen, C.R. DeWitt, Z.-C. Fan, L. Shan, C. Faber, B.L. Hanson, C.A.K. Borrebaeck (1998) Designing Fabs and Fvs with propensities to crystallize.  The Immunologist 6: 54-60.

Microbiology of Infectious Disease

Dept. of Science and Mathematics, Oklahoma City Community College, summer semester 2003

Textbooks: Microbiology: A Human Perspective and Mi